$1.50
0.04[2.74%]
At close: Apr 19
$1.50
0[0.00%]
After Hours: 7:52PM EDT
Pacific Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pacific Biosciences using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | PM | PACB | Q1 | -$0.31 | -$0.27 | — | — | $38.90M | $50.25M | — | — | Get Alert |
02/15/2024 | PM | PACB | Q4 | -$0.35 | -$0.28 | -$0.27 | 3.57% | $27.35M | $57.49M | $58.36M | 1.51% | Get Alert |
10/30/2023 | PM | PACB | Q3 | -$0.32 | -$0.32 | -$0.27 | 15.62% | $32.31M | $48.76M | $55.69M | 14.21% | Get Alert |
08/02/2023 | PM | PACB | Q2 | -$0.34 | -$0.32 | -$0.26 | 18.75% | $35.47M | $40.30M | $47.57M | 18.05% | Get Alert |
05/02/2023 | PM | PACB | Q1 | -$0.37 | -$0.33 | -$0.31 | 6.06% | $33.17M | $34.38M | $38.90M | 13.15% | Get Alert |
02/16/2023 | PM | PACB | Q4 | -$0.30 | -$0.36 | -$0.35 | 2.78% | $36.02M | $26.24M | $27.35M | 4.24% | Get Alert |
11/07/2022 | PM | PACB | Q3 | -$0.23 | -$0.33 | -$0.32 | 3.03% | $34.89M | $35.40M | $32.31M | -8.73% | Get Alert |
08/03/2022 | PM | PACB | Q2 | -$0.21 | -$0.32 | -$0.34 | -6.25% | $30.61M | $35.70M | $35.47M | -0.65% | Get Alert |
05/04/2022 | PM | PACB | Q1 | -$0.45 | -$0.31 | -$0.37 | -19.35% | $29.00M | $32.82M | $33.17M | 1.08% | Get Alert |
02/15/2022 | PM | PACB | Q4 | $0.37 | -$0.28 | -$0.30 | -7.14% | $27.14M | $36.12M | $36.02M | -0.28% | Get Alert |
11/02/2021 | PM | PACB | Q3 | -$0.14 | -$0.22 | -$0.23 | -4.55% | $19.08M | $33.23M | $34.89M | 4.99% | Get Alert |
08/03/2021 | PM | PACB | Q2 | -$0.15 | -$0.20 | -$0.21 | -5.00% | $17.08M | $29.89M | $30.61M | 2.41% | Get Alert |
04/29/2021 | PM | PACB | Q1 | $0.01 | -$0.45 | -$0.45 | 0.00% | $15.60M | $25.67M | $29.00M | 12.96% | Get Alert |
02/10/2021 | PM | PACB | Q4 | $0.00 | $0.32 | $0.37 | 15.62% | $27.93M | $25.41M | $27.14M | 6.79% | Get Alert |
11/02/2020 | PM | PACB | Q3 | -$0.19 | -$0.13 | -$0.14 | -7.69% | $21.91M | $20.35M | $19.08M | -6.23% | Get Alert |
08/03/2020 | PM | PACB | Q2 | -$0.16 | -$0.18 | -$0.15 | 16.67% | $24.62M | $13.72M | $17.08M | 24.47% | Get Alert |
05/06/2020 | PM | PACB | Q1 | -$0.20 | -$0.16 | $0.01 | 106.25% | $16.43M | $20.07M | $15.60M | -22.28% | Get Alert |
02/06/2020 | PM | PACB | Q4 | -$0.21 | -$0.16 | $0.00 | 100.00% | $19.53M | $25.52M | $27.93M | 9.44% | Get Alert |
11/07/2019 | PM | PACB | Q3 | -$0.19 | — | -$0.19 | — | $18.16M | — | $21.91M | — | Get Alert |
Pacific Biosciences (PACB) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on February 15, 2024 for Q4.
The Actual EPS was $-0.27, which beat the estimate of $-0.28.
The Actual Revenue was $58.4M, which beat the estimate of $57.5M.
Browse earnings estimates, EPS, and revenue on all stocks.